HCA Holdings (NYSE: HCA) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Tuesday. The firm currently has a $38.70 price target on the stock.

A number of other firms have also recently commented on HCA. Analysts at TheStreet reiterated a “sell” rating on shares of HCA Holdings in a research note to investors on Thursday, March 7th. Separately, analysts at Susquehanna reiterated a “positive” rating on shares of HCA Holdings in a research note to investors on Tuesday, February 12th. They now have a $45.00 price target on the stock. Finally, analysts at Morgan Stanley initiated coverage on shares of HCA Holdings in a research note to investors on Monday, February 11th. They set an “overweight” rating and a $47.00 price target on the stock.

Twenty investment analysts have rated the stock with a buy rating, two have issued an overweight rating, and seven have issued a hold rating to the stock. The company presently has a consensus rating of “overweight” and an average price target of $43.29.

Shares of HCA Holdings traded up 0.58% during mid-day trading on Tuesday, hitting $38.0099. HCA Holdings has a one year low of $22.95 and a one year high of $39.60. The stock’s 50-day moving average is currently $36.94. The company has a market cap of $16.862 billion and a P/E ratio of 10.83.

HCA Holdings last announced its earnings results on Tuesday, February 5th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. The company had revenue of $8.43 billion for the quarter, compared to the consensus estimate of $8.95 billion. During the same quarter in the previous year, the company posted $0.94 earnings per share. The company’s revenue for the quarter was up 13.2% on a year-over-year basis. HCA Holdings has set its FY13 guidance at $3.00-3.30 EPS. Analysts expect that HCA Holdings will post $3.18 EPS for the current fiscal year.

HCA Holdings, Inc. (HCA) is a holding company whose affiliates owns and operates hospitals and related health care entities.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.